Neuroinflammatory processes in Alzheimer’s disease

Heneka, Michael T., O’Banion, M. Kerry, Terwel, Dick, Kummer, Markus Peter·2010·Journal of Neural Transmission
DOI 10.1007/s00702-010-0438-z

Cited by (432)

Items 301–400 of 432

  1. Cerebrospinal fluid levels of synaptic and neuronal integrity correlate with gray matter volume and amyloid load in the precuneus of cognitively intact older adults
    Jolien M. Schaeverbeke, Benjamin Gille, Katarzyna Adamczuk, Hugo Vanderstichele, Emeric Chassaing, Rose Bruffaerts, Veerle Neyens, Erik Stoops, Jos Tournoy, Rik R. Vandenberghe et al. · 2019 · Journal of Neurochemistry
  2. Cobalt(II) β-ketoaminato complexes as novel inhibitors of neuroinflammation
    Jocelyn M. Madeira, Natalia Beloukhina, Kalun Boudreau, Tyson A. Boettcher, Lydia Gurley, Douglas G. Walker, W. Stephen McNeil, Andis Klegeris · 2011 · European Journal of Pharmacology
  3. Relationship of angiogenesis and microglial activation to seizure-induced neuronal death in the cerebral cortex of Shetland Sheepdogs with familial epilepsy
    Masashi Sakurai, Takehito MORITA, Takashi Takeuchi, Akinori Shimada · 2013 · American Journal of Veterinary Research
  4. In Silico Insight into Potential Anti-Alzheimer’s Disease Mechanisms of Icariin
    Zhijie Cui, Zhen Sheng, Xinmiao Yan, Zhiwei Cao, Kailin Tang · 2016 · International Journal of Molecular Sciences
  5. Chronic Toxoplasma gondii Infection Potentiates Parkinson’s Disease Course in Mice Model
    Nima Firouzeh, Naser Ziaali, Vahid Sheibani, Amir Hossein Doustimotlagh, Ali Afgar, Maryam Zamanpour, Hossein Keshavarz, Saeideh Shojaee, Reza Shafiei, Khadijeh Esmaeilpour et al. · 2021 · Iranian Journal of Parasitology
  6. PL201, a Reported Rhamnoside Against Alzheimer's Disease Pathology, Alleviates Neuroinflammation and Stimulates Nrf2 Signaling
    Yuqian An, Hong Zhang, Shichao Huang, Gang Pei · 2020 · Frontiers in Immunology
  7. The critical role of piperamide derivative D4 in the regulation of inflammatory response by the microglia and astrocytic glial cells
    Sajad Shahbazi, Tara Zakerali, Bartosz Adam Frycz, Jagdeep Kaur · 2020 · Biomedicine & Pharmacotherapy
  8. N-Terminal Pro-B Type Natriuretic Peptide is Associated with Mild Cognitive Impairment in the General Population
    Kaffer Kara, Amir Abbas Mahabadi, Christian Weimar, Angela Winkler, Till Neumann, Hagen Kälsch, Nico Dragano, Susanne Moebus, Raimund Erbel, Karl‐Heinz Jöckel et al. · 2016 · Journal of Alzheimer s Disease
  9. Intravenous Immunglobulin Binds Beta Amyloid and Modifies Its Aggregation, Neurotoxicity and Microglial Phagocytosis In Vitro
    Susann Cattepoel, Alexander Schaub, Miriam Ender, Annette Gaida, Alain Kropf, Ursula Guggisberg, Marc Wolfgang Nolte, Louis Fabri, Paul Anthony Adlard, David Isaac Finkelstein et al. · 2013 · PLoS ONE
  10. Therapeutic utility of glucocorticoids and antihistamines cotreatment. Rationale and perspectives
    Carlos Daniel Zappia, Federico Monczor · 2019 · Pharmacology Research & Perspectives
  11. Tacrine-sugar mimetic conjugates as enhanced cholinesterase inhibitors
    Quelli Larissa Oliveira de Santana, Tereza Cristina Santos Evangelista, Petra Imhof, Sabrina Baptista Ferreira, José G. Fernández‐Bolaños, Magne Olav Sydnes, Óscar López, Emil Lindbäck · 2021 · Organic & Biomolecular Chemistry
  12. Aging-Related Protein Alterations in the Brain
    Rafay Ali Syed, Mahnoor Hayat, Hammad Qaiser, Mohammad Uzair, Khalid Al-Regaiey, Roaa A. Khallaf, Imdad Kaleem, Shahid Bashir · 2024 · Journal of Alzheimer s Disease
  13. C-Reactive Protein Induces Tau Hyperphosphorylation via GSK3β Signaling Pathway in SH-SY5Y Cells
    Haibiao Guo, Haitao Wang, Canmao Wang, Yufang Cheng, Zhengqiang Zou, Yiwen Li, Jingang Wu, Jiangping Xu · 2015 · Journal of Molecular Neuroscience
  14. Primary motor cortex alterations in Alzheimer disease: a study in the 3xTg-AD model
    Erika Orta‐Salazar, Alfredo Feria‐Velasco, Sofía Y. Díaz-Cintra · 2019 · Neurología (English Edition)
  15. BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers
    Óscar López-Pérez, Marcos Bernal-Martin, Adelaida Hernaiz, Franc Llorens, Marina Betancor, Alicia Otero, Janne M. Toivonen, P. Zaragoza, Inga Zerr, Juan José Badiola et al. · 2020 · Biomolecules
  16. Nonlinear and vibrational microscopy for label-free characterization of amyloid-β plaques in Alzheimer's disease model
    Renan Souza Cunha, Lucas Lafetá, Emerson Alberto Fonseca, Alexandre Simões Barbosa, Marco Aurélio Romano‐Silva, Rafael Pinto Vieira, Ado Jório, Leandro M. Malard · 2021 · The Analyst
  17. A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer’s Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants
    Maria Tsamou, Francesca Pistollato, Erwin Roggen · 2021 · Journal of Alzheimer s Disease
  18. Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment
    Umang Shah, Aneri Shah, Sandip Pravin Patel, Alkesh Patel, Mehul M. Patel, Nilay D. Solanki, Swayamprakash Patel, Ashish D. Patel, Veena Patel, Bhavesh Patel · 2022 · CNS & Neurological Disorders - Drug Targets
  19. Neuroprotective effect of Chunghyuldan from amyloid beta oligomer induced neuroinflammation in vitro and in vivo
    Hyo Geun Kim, J. S. Kim, Wei‐Wan Whang, Myung Sook Oh · 2014 · Canadian Journal of Physiology and Pharmacology
  20. Deficiency in EP4 Receptor–Associated Protein Ameliorates Abnormal Anxiety-Like Behavior and Brain Inflammation in a Mouse Model of Alzheimer Disease
    Risako Fujikawa, Sei Higuchi, Masato Nakatsuji, Mika Yasui, Taichi Ikedo, Manabu Nagata, Kosuke Hayashi, Masayuki Yokode, Manabu Minami · 2017 · American Journal Of Pathology
  21. PREVALENCE OF MICROBIAL RESISTANCE TO CHLORHEXIDINE: A SYSTEMATIC REVIEW AND ANALYSIS OF REGIONAL MONITORING
    D. V. Kvashnina, Olga V. Kovalishena · 2018 · Fundamental and Clinical Medicine
  22. Design, Synthesis, Biological Evaluation and Molecular Dynamics Simulations Study of Genistein‐ O ‐1,3,5‐Triazine Derivatives as Multifunctional Anti‐Alzheimer Agents
    Jing‐Pei Zou, Jing‐Jing Qian, Shan‐Ming Liu, Rui Li, Xiaoqing Zhang, Shun Yang, Yuwei Liu, Weiwei Liu, Shaojie Ma, Da‐Hua Shi · 2022 · ChemistrySelect
  23. ABDOMINOPLASTY TECHNIQUES: A HISTORICAL PERSPECTIVE AND CURRENT VIEW ON MAKING INCISIONS
    SOFIA I. PLEGUNOVA, Vadim Alexandrovich Zotov, OLGA O. POBEREZHNAYA · 2018 · Fundamental and Clinical Medicine
  24. PRO-INFLAMMATORY PHENOTYPE OF PERIVASCULAR ASTROCYTES AND CD133+ ENDOTHELIAL PROGENITOR CELLS IN MURINE MODEL OF ALZHEIMER’S DISEASE
    Anatoliy I. Chernykh, Yuliya К. Komleva, Yana V. Gorina, Olga L. Lopatina, SVETLANA I. PASCHENKO, Alla B. Salmina · 2018 · Fundamental and Clinical Medicine
  25. Association of early-onset Alzheimer’s disease with germline-generated high affinity self-antigen load
    Po-Yin Samuel Huang, Yuan‐Han Yang, Ya-Hsuan Chang, Shu-Ling Chang, Mei‐Chuan Chou, Chiou‐Lian Lai, Ching‐Kuan Liu, Hsuan‐Yu Chen · 2020 · Translational Psychiatry
  26. Trichoderma reesei fungal degradation boosted the potentiality of date pit extract in fighting scopolamine-induced neurotoxicity in male rats
    Samar R. Saleh, Asmaa M Masry, D. Ghareeb, A. A. Newairy, E. Sheta, Adham M. Maher · 2021 · Scientific Reports
  27. A complex role of chromogranin A and its peptides in inflammation, autoimmunity, and infections
    Maciej Maj, Karolina Hernik, Kaja Tyszkiewicz, Maja Owe-Larsson, Alicja Sztokfisz-Ignasiak, Jacek Malejczyk, Izabela Róża Janiuk · 2025 · Frontiers in Immunology
  28. KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer’s disease
    Bolívar Arcos-Encarnación, Eladio Cortes-Flores, Isabel Barón-Mendoza, Jorge Luis Almazán, David Valle‐García, Sol Díaz de León‐Guerrero, Ladislav Hovan, Karla F. Meza‐Sosa, Nohemí Camacho‐Concha, Jeovanis Gil et al. · 2025 · Journal of Neuroinflammation
  29. Unwanted Exacerbation of the Immune Response in Neurodegenerative Disease: A Time to Review the Impact
    Amanda de Oliveira Ferreira Leite, João Bento‐Torres, Renata Rodrigues dos Reis, Luciane Lobato Sobral, Aline Cristine Passos de Souza, Nonata Trévia, Roseane Borner de Oliveira, Nara Alves de Almeida Lins, Daniel Guerreiro Diniz, José Antônio Picanço Diniz et al. · 2021 · Frontiers in Cellular Neuroscience
  30. Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline
    Stefan Johannes Teipel, Martin Dyrba, Luca Kleineidam, Frederic Brosseron, Fedor Levin, Davide Bruno, Katharina Büerger, Nicoleta Carmen Cosma, Luisa‐Sophie Schneider, Emrah Düzel et al. · 2024 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  31. Antagonistic Roles of P2X7 and P2Y2 Receptors in Neurodegenerative Diseases
    Talita Glaser, Ágatha Oliveira‐Giacomelli, Lyvia Lintzmaier Petiz, Deidiane Elisa Ribeiro, Roberta Andrejew, Henning Ulrich · 2021 · Frontiers in Pharmacology
  32. The molecular pathology of neurodegenerative and psychiatric disorders
    Peipei Yan, Yi Ming Deng, Xi Su, Hesheng Kong, Yichi Zhang, Wenqiang Li, Eryan Kong · 2023 · Elsevier eBooks
  33. Role of inflammation in the socioeconomic inequalities of neurocognitive disorders
    Aswathikutty Gireesh, Amanda Sacker, Anne McMunn, Dorina Cadar · 2023 · Brain Behavior and Immunity
  34. Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease
    Rachel A. Matt, Renée S. Martin, Andrew K. Evans, Joel R. Gever, Gabriel A. Vargas, Mehrdad Shamloo, Anthony P.D.W. Ford · 2023 · Handbook of experimental pharmacology
  35. A novel rhamnoside derivative PL402 up-regulates matrix metalloproteinase 3/9 to promote Aβ degradation and alleviates Alzheimer’s-like pathology
    Tingting Hu, Yue Zhou, Jing Nan Lu, Peng Xia, Yue Chen, Xin Cao, Gang Pei · 2020 · Aging
  36. Blindness and hypoglycemia: growth hormone deficiency with septo-optic dysplasia.
    E A Clark, Walter J. Meyer · 1978 · PubMed
  37. Sustained Alzheimer's Amyloid Pathology in Myeloid Differentiation Protein-88-Deficient APPswe/PS1 Mice
    Yael Goll, Uriya Bekenstein, Shahar Barbash, David Greenberg, R. Zangen, Shawn Shoham, Hermona Soreq · 2013 · Neurodegenerative Diseases
  38. S100B and Latent Toxoplasmosis in Alzheimer’s disease
    Hakan Ayyıldız · 2019 · International journal of medical biochemistry/International journal of medical biochemistry :
  39. Ageing, Metabolic Dysfunction, and the Therapeutic Role of Antioxidants
    Ana L. Santos, Sanchari Sinha · 2023 · Sub-cellular biochemistry/Subcellular biochemistry
  40. Amyloid β,α-Synuclein and Amyloid β-α-Synuclein Combination Exert Significant but Different Alterations in Inflammatory Response Profile in Differentiated Human SH-SY5Y Cells
    Ebru Keskin, Duygu Gezen‐Ak, Erdinç Dursun · 2023 · ACS Omega
  41. New insights on Alzheimer's disease
    Randa Abdel Kader Mahmoud El-Desouki · 2014 · Journal of Microscopy and Ultrastructure
  42. P2–005: Low platelet PLA2 activity predicts conversion from mild cognitive impairment to Alzheimer's disease: A 4‐year follow‐up study
    Wagner F. Gattaz, Leda Leme Talib, Evelin Shaeffer, Breno Satler Diniz, Orestes Vicente Forlenza · 2013 · Alzheimer s & Dementia
  43. The contribution of type-I IFN-mediated neuroinflammation to Parkinson's disease progression
    Shuyan Chen, Peter John Crack, Juliet Marie Taylor · 2025 · Brain Behavior & Immunity - Health
  44. Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant
    Daniel Felsky, Philip L. De Jager, Julie A. Schneider, Konstantinos Arfanakis, Debra A. Fleischman, Zoe Arvanitakis, William G. Honer, Jennie G. Pouget, Romina Mizrahi, Bruce G. Pollock et al. · 2016 · Journal of Cerebral Blood Flow & Metabolism
  45. Astrocyte-microglia interaction in the expression of a pro-inflammatory or pain-related phenotype: molecular and cellular aspects
    Massimo Barbierato · 2012 · Padua Research Archive (University of Padova)
  46. CD28+ CD45RA− CD8br AC mediated the effects of Interleukin- 6 on Alzheimer's disease: A Mendelian Randomization Study
    Rui‐Hua Xu, YongJun Gao · 2025 · BMC Neurology
  47. Saroglitazar Enhances Memory Functions and Adult Neurogenesis via Up-Regulation of Wnt/β Catenin Signaling in the Rat Model of Dementia
    Sandeep Kumar Mishra, Vaibhav Mishra · 2024 · ACS Chemical Neuroscience
  48. Locus coeruleus integrity correlates with plasma soluble Axl levels in Alzheimer's disease patients
    Alessandro Galgani, Arnaud Mary, Francesco Paolo Lombardo, Nicola Martini, Marco Scotto, Gloria Tognoni, Gabriele Siciliano, Roberto Ceravolo, Filippo Sean Giorgi, Michael Thomas Heneka · 2025 · Alzheimer s & Dementia
  49. Effects of autologous serum on TREM2 and APOE in a personalized monocyte-derived macrophage assay of late-onset Alzheimer’s patients
    Neriman Eren, Susanna Gerike, Berk Üsekes, Oliver Peters, Nicoleta Carmen Cosma, Julian Hellmann‐Regen · 2023 · Immunity & Ageing
  50. Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies
    Alessandro Galgani, Giovanni Palermo, Francesco Paolo Lombardo, Nicola Martini, Luca Bastiani, Andrea Vergallo, Luca Tommasini, Gabriele Bellini, Filippo Baldacci, Daniela Frosini et al. · 2023 · Current Alzheimer Research
  51. The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
    Yvonne Bouter · 2015
  52. The Fourth Element Targeting Hypothesis of Alzheimer's Disease Pathogenesis and Pathophysiology
    Rodrigo Orlando Kuljiš · 2010 · Frontiers in Neurology
  53. CURRENT OPINION ON TAXONOMY, MORPHOLOGICAL, AND FUNCTIONAL PROPERTIES OF BIFIDOBACTERIA
    Yuliya Zakharova, Lyudmila A. Levanova · 2018 · Fundamental and Clinical Medicine
  54. 2D Images of Astrocytes in the Human Principal Olivary Nucleus: Monofractal Analysis of the Morphology
    Damjan Stojić, Dragana Radošević, Nemanja Rajković, Nebojša T. Milošević · 2021 · Journal of Biosciences and Medicines
  55. The role of immunity and neuroinflammation in genetic predisposition and pathogenesis of Alzheimer’s disease
    Seoyoung Yoon, Yong‐Ku Kim · 2015 · Global Medical Genetics
  56. Astaxanthin and Fucoxanthin
    Mariana Barbosa, Patrı́cia Valentão, Paula B. Andrade · 2020 · Encyclopedia of Marine Biotechnology
  57. Vibrotactile stimulation at 40 Hz inhibits Aβ-induced changes in SH-SY5Y, BV2 cells, and pericytes
    Chang-Ho Shin, Byung-Woo Kang, Min-Woo Cho, Jae-Young Ha, Jai Jun Choung, Dong‐Keun Song, Hee‐kyoung Ko, Myeong-Hyun Nam, Young‐Kwon Seo · 2024 · Brain Research Bulletin
  58. Changes in RBM47 expression based on the timing of melatonin administration and its effects on Nrf2 activity in the hippocampus
    Hye-Sun Lim, Seung Hoon Lee, Huiyun Seo, Gunhyuk Park · 2023 · Free Radical Biology and Medicine
  59. Neuroinflammatory Responses Occur in Brain Lesions During Alzheimer’s Disease: Postmortem Case Report
    Mourad Belkhelfa, Samy Bekrar, Lina Rezaig, Narimene Beder, Faiza Touri, Yamina Yousfi, Hedia Nabi, Assia Slimani, Nabila Attal, Ayed Belarbi et al. · 2024 · Journal of Alzheimer s Disease
  60. Targeting angiogenesis, inflammation, and oxidative stress in Alzheimer's diseases
    Manorama Bhandari, R.K. Tiwari, Silpi Chanda, Gunjan Vasant Bonde · 2024 · Elsevier eBooks
  61. Bryostatin-1 protects against amyloid- beta (Aβ) oligomer-induced neurotoxicity by activating autophagy
    Peng Chen, Wenyang Pan, Misona Kum, Xiaofeng Bao · 2024 · Brazilian Journal of Pharmaceutical Sciences
  62. The chalcone derivative Chana 1 protects against amyloid�β peptide-induced oxidative stress and cognitive impairment
    Yoo-Hyun Lee · 2012 · International Journal of Molecular Medicine
  63. Pathogenesis, modulation, and therapy of Alzheimer’s disease: A perspective on roles of liver-X receptors
    Jasminka Štefulj, Ute Panzenboeck, Patrick R. Hof, Goran Šimić · 2013 · Translational Neuroscience
  64. Comparative Analysis of Deep Learning and Machine Learning Models for Alzheimer’s and Parkinson’s Disease Classification from Medical Images
    Muskan Dixit, Aman Kumar Mishra, Isha Kansal, Vikas Khullar, Ashish Kumar · 2024 · International Conference on Electrical Electronics and Computing Technologies (ICEECT)
  65. Carnosine protects human microglia against Aβ oligomers through a multimodal mechanism of action: inhibition of oxidative stress, rescue of cellular energy status, and enhancement of phagocytosis
    Anna Privitera, Vincenzo Cardaci, Matthew C. Zupan, Lucia Di Pietro, Giuseppe Carota, Jay Sibbitts, Renata Mangione, Andréa Graziani, Lucia Buccarello, Francesco Bellia et al. · 2026 · Frontiers in Immunology
  66. N-3 PUFAs and neuroinflammatory processes in cognitive disorders
    Quentin Leyrolle, Sophie Layé, Agnès Nadjar · 2016 · OCL
  67. Iodine in Disruption of Thyroid and Thyroid Hormone Receptive Systems
    Amar Kumar Chandra · 2021 · Proceedings of the Zoological Society
  68. Apocynaceae as a Potential Source for Acetylcholinesterase Inhibition in Symptomatic Regulation and Management of Alzheimer's Disease
    Priyanka Kumari, Naveen Sarwa, Deepak Meena, Ajaya Eesha, Navneet Singh Chaudhary · 2024 · Current Enzyme Inhibition
  69. Mechanism of inhibition of TLR4/NFκB/NLRP3 inflammatory pathway against AD based on the network pharmacology of Erjing Pills
    Chen Zhang, Mingjing Lu, C. Li, Chao Qi, Qian Lin, LiPing Huang, Hailing Ding · 2024 · Medicine
  70. Inflammation, Immune System and Alzheimer's disease: A Review of the Findings from the Major GWAS Studies
    Christiane Reitz, Giuseppe Tosto · 2013 · Journal of Molecular and Genetic Medicine
  71. Heat Shock Proteins, a Key Modulator of Neuroinflammation in Alzheimer’s Disease
    Komal Panchal, Vidhi Bhatt, Mahima Raval, Anand Krishna Tiwari · 2020 · Heat shock proteins
  72. Neuroinflammation in depression
    Niki Dobos · 2014 · University of Groningen research database (University of Groningen / Centre for Information Technology)
  73. Energy-Dependent Mechanisms of Cholinergic Neurodegeneration
    Agnieszka Jankowska-Kulawy, Anna Ronowska, Andrzej Szutowicz · 2014 · InTech eBooks
  74. Эффекты природного органического пигмента астаксантина и перспективы его применения при болезни Альцгеймера
    И К Малашенкова, Алла Анатольевна Селищева, Евгений Александрович Куликов, Daniil Ogurtsov, Sergey Krynskiy, Наталья Юрьевна Лотош, Svetlana N. Moskvina, Б.М. Величковский · 2021 · Экспериментальная и клиническая фармакология
  75. Effects of metal oxide inhalation on the transcription of some hormone receptors in the brain, examined in an in vivo mouse model
    Dávid Sándor Kiss, István Tóth, Tibor Bartha, Ákos Jerzsele, Attila Zsarnovszky, Erzsébet Pászti-Gere, Silvia Ondrašovičová, Petra Varró, Csaba Kővágó · 2024 · Environmental Science and Pollution Research
  76. Comparative Analysis of Human Brain RNA-seq Reveals the Combined Effects of Ferroptosis and Autophagy on Alzheimer’s Disease in Multiple Brain Regions
    Ke Ye, Xue Ling Zhao, Lulu Liu, Fangliang Ge, Feifei Zheng, Zijie Liu, Mengjie Tian, Xinyu Han, Xu Gao, Qing Hua Xia et al. · 2024 · Molecular Neurobiology
  77. Pharmacological Effects and Molecular Mechanisms of Lignans in the Treatment of Alzheimer’s Disease
    Limeng Sun, Xingyu Zhu, Chunyan Fan, Yu Wang, Q Chen, Li Zhang, Yu Zhang, Ying Liu · 2026 · Molecules
  78. Biological Basis for Cerebral Dysfunction in Schizophrenia in Contrast with Alzheimer’s Disease
    Rodrigo Orlando Kuljiš, Luis V. Colom, Leonel E. Rojo · 2014 · Frontiers in Psychiatry
  79. THEORY OF CONTAGION AS A DRIVER OF PROGRESS IN EPIDEMIOLOGY?
    А И Блох · 2018 · Fundamental and Clinical Medicine
  80. Antiinflammatory Properties of Dietary n-3 Polyunsaturated Fatty Acids Protect Against Cognitive Decline in Aging and Neurodegenerative Diseases
    Agnès Nadjar, Quentin Leyrolle, Corinne Joffre, Sophie Layé · 2018 · Elsevier eBooks
  81. TNF signaling via TNF receptors does not mediate the effects of short-term exercise on cognition, anxiety and depressive-like behaviors in middle-aged mice
    Gaurav Singhal, Magdalene C. Jawahar, Julie Morgan, Frances Corrigan, Emily Joy Jaehne, Catherine G. Toben, Anthony John Hannan, Shalem Leemaqz, Bernhard Theodor Baune · 2021 · Behavioural Brain Research
  82. Antibodies to Glutamate Reduce the IL-6 Content in Cerebral Structures in Mice with Age-Related Memory Impairment
    Tatiana V. Davydova, L. A. Vetrilé, Zakharova Ia · 2024 · Bulletin of Experimental Biology and Medicine
  83. Inflammasomes Action as an Important Mechanism in Experimental and Clinical Depression
    Gaurav Singhal, Bernhard Theodor Baune · 2018 · Elsevier eBooks
  84. ASSOCIATION OF MINERAL BONE DENSITY AND RISK OF OSTEOPOROTIC FRACTURES WITH CORONARY AND CAROTID ATHEROSCLEROSIS IN MALE PATIENTS WITH STABLE ANGINA
    A. V. Voronkina, TATIANA A. RASKINA, Marina Vasilyevna Letaeva, E. Malyuta, ALEXANDR N. KOKOV, О. Л. Барбараш · 2018 · Fundamental and Clinical Medicine
  85. An Investigation on the Interaction of Various Natural Products with the Amyloid-β Peptide; Betulinic Acid Causes Rapid Amyloid-β Fibril Formation at the Expense of Soluble Oligomers
    Matthew S. Planchard · 2012 · Aquila Digital Community (University of Southern Mississippi)
  86. Inflammatory Roads to Neurodegeneration: A Focus on Parkinson's and Alzheimer's Disease
    Shawn P. Hayley, Darcy Litteljohn · 2013
  87. WNT SIGNALING IN MICROGLIA
    Carina Halleskog · 2013
  88. Neurogenesis in the adult brain, gene networks, and Alzheimer's Disease
    Emrin Horgusluoglu · 2017 · IUScholarWorks (Indiana University)
  89. PROTEOMIC COMPARISON OF EXTRACELLULAR MATRIX WITHIN LIVER METASTASES OF COLORECTAL CANCER AND NORMAL LIVER
    Arseniy E. Yuzhalin, Ruth J. Muschel · 2018 · Fundamental and Clinical Medicine
  90. Neuroinflammation
    Joseph M. Gullett · 2019 · Springer eBooks
  91. Microglial involvement in brain physiopathology: in vitro studies using rat primary cultures
    Ilaria Mengoni · 2014 · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)
  92. WNT SIGNALING IN MICROGLIA
    Carina Halleskog · 2013 · Figshare
  93. Systems Regulating and Inducing Dopaminergic Cell Death in Parkinson’s Disease: an Analysis of Signalling Associated with Parkinson's Disease Models
    MatthewP Mount · 2015 · uO Research (University of Ottawa)
  94. N-3 Polyunsaturated Fatty Acid and Neuroinflammation in Aging: Role in Cognition
    Sophie Layé, Charlotte Madore, Jean-Christophe Delpech, Corinne Joffre, Agnès Nadjar · 2014 · AAPS advances in the pharmaceutical sciences series
  95. Regenerating the brain: Stem cell differentiation and cholinergic dysfunction in Alzheimer disease
    Linn Malmsten · 2014 · Figshare
  96. Rapid Cycling and Lower Hemoglobin in Elderly Bipolar Patients with Brain Atrophy
    Pao‐Huan Chen, Shang‐Ying Tsai, Jung-Lung Hsu, Hui‐Wen Lin, Shou‐Hung Huang, Kuo‐Hsuan Chung · 2013 · Journal of Experimental & Clinical Medicine
  97. ABCA1, Apoe and apoA-I As Potential Therapeutic Targets for Treating Alzheimer’s Disease
    Dhananjay Namjoshi, Sophie K. Stukas, Cheryl Lea Wellington · 2011 · Neurodegenerative Disease Management
  98. Pooled results of two small trials with few events show a non-significant trend towards increased risk of intracerebral haemorrhage in people with Alzheimer's disease
    Barbara E. Harrison · 2011 · Evidence-Based Nursing
  99. Characterisation of transgenic mouse models of Alzheimer's disease
    Lindsay Graham · 2011 · OpenGrey (Institut de l'Information Scientifique et Technique)
  100. Investigação do efeito neuroprotetor da atorvastatina em um modelo in vitro de toxicidade induzida pelo peptídeo β-amiloide
    Thaline da Silva · 2012 · Americanae (AECID Library)